Hongming Chen obtained his PhD in computational chemistry in 1998 from the Institute of Chemical Metallurgy, Chinese Academy of Sciences. After working as postdoctoral fellow in computational chemistry in Bayer Pharma Research Center in Wuppertal, Germany, he joined AstraZeneca R&D Mölndal, Sweden, in 2001. He held a Principal Scientist position in Hit Discovery of Discovery Sciences, AstraZeneca. In 2019, he took a Professor/Principal Investigator position in Guangzhou Regenerative Medicine and Health - Guangdong Laboratory (GRMH-GDL). He has been focusing in Chemoinformatics, artificial intelligence/machine learning area and coauthored over 60 scientific publications/patents.
This project is funded by Horizon2020 research and innovation programme under the Marie Skłodowska-Curie actions